117 related articles for article (PubMed ID: 8932329)
1. Expression of the zinc finger gene EVI-1 in ovarian and other cancers.
Brooks DJ; Woodward S; Thompson FH; Dos Santos B; Russell M; Yang JM; Guan XY; Trent J; Alberts DS; Taetle R
Br J Cancer; 1996 Nov; 74(10):1518-25. PubMed ID: 8932329
[TBL] [Abstract][Full Text] [Related]
2. Pathogenetic significance of ecotropic viral integration site-1 in hematological malignancies.
Goyama S; Kurokawa M
Cancer Sci; 2009 Jun; 100(6):990-5. PubMed ID: 19385966
[TBL] [Abstract][Full Text] [Related]
3. Evi-1 promotes para-aortic splanchnopleural hematopoiesis through up-regulation of GATA-2 and repression of TGF-b signaling.
Sato T; Goyama S; Nitta E; Takeshita M; Yoshimi M; Nakagawa M; Kawazu M; Ichikawa M; Kurokawa M
Cancer Sci; 2008 Jul; 99(7):1407-13. PubMed ID: 18452556
[TBL] [Abstract][Full Text] [Related]
4. Novel population of small tumour-initiating stem cells in the ovaries of women with borderline ovarian cancer.
Virant-Klun I; Stimpfel M
Sci Rep; 2016 Oct; 6():34730. PubMed ID: 27703207
[TBL] [Abstract][Full Text] [Related]
5. The urothelial gene regulatory network: understanding biology to improve bladder cancer management.
Ramal M; Corral S; Kalisz M; Lapi E; Real FX
Oncogene; 2024 Jan; 43(1):1-21. PubMed ID: 37996699
[TBL] [Abstract][Full Text] [Related]
6. High EVI1 and PARP1 expression as favourable prognostic markers in high-grade serous ovarian carcinoma.
Jank P; Leichsenring J; Kolb S; Hoffmann I; Bischoff P; Kunze CA; Dragomir MP; Gleitsmann M; Jesinghaus M; Schmitt WD; Kulbe H; Sers C; Stenzinger A; Sehouli J; Braicu IE; Westhoff C; Horst D; Denkert C; Gröschel S; Taube ET
J Ovarian Res; 2023 Jul; 16(1):150. PubMed ID: 37525239
[TBL] [Abstract][Full Text] [Related]
7. EVI1 expression in early-stage breast cancer patients treated with neoadjuvant chemotherapy.
Leichsenring J; Vladimirova V; Solbach C; Karn T; Ataseven B; Sinn BV; Barinoff J; Müller V; Blohmer JU; Schem C; Engels K; Marmé F; Fisseler-Eckhoff A; Fasching PA; Stickeler E; van Mackelenbergh M; Denkert C; Stenzinger A; Loibl S; Gröschel S
BMC Cancer; 2022 Oct; 22(1):1040. PubMed ID: 36195836
[TBL] [Abstract][Full Text] [Related]
8. Phenotypic heterogeneity in individuals with MECOM variants in 2 families.
Niihori T; Tanoshima R; Sasahara Y; Sato A; Irie M; Saito-Nanjo Y; Funayama R; Shirota M; Abe T; Okuyama Y; Ishii N; Nakayama K; Kure S; Imaizumi M; Aoki Y
Blood Adv; 2022 Sep; 6(18):5257-5261. PubMed ID: 35020829
[No Abstract] [Full Text] [Related]
9. Emerging Roles of PRDM Factors in Stem Cells and Neuronal System: Cofactor Dependent Regulation of PRDM3/16 and FOG1/2 (Novel PRDM Factors).
Leszczyński P; Śmiech M; Parvanov E; Watanabe C; Mizutani KI; Taniguchi H
Cells; 2020 Dec; 9(12):. PubMed ID: 33291744
[TBL] [Abstract][Full Text] [Related]
10. EVI1 in Leukemia and Solid Tumors.
Liang B; Wang J
Cancers (Basel); 2020 Sep; 12(9):. PubMed ID: 32962037
[TBL] [Abstract][Full Text] [Related]
11. Multifaceted Role of PRDM Proteins in Human Cancer.
Casamassimi A; Rienzo M; Di Zazzo E; Sorrentino A; Fiore D; Proto MC; Moncharmont B; Gazzerro P; Bifulco M; Abbondanza C
Int J Mol Sci; 2020 Apr; 21(7):. PubMed ID: 32290321
[TBL] [Abstract][Full Text] [Related]
12. Downregulation of EVI1 Expression Inhibits Cell Proliferation and Induces Apoptosis in Hilar Cholangiocarcinoma via the PTEN/AKT Signalling Pathway.
Zhang XM; Liu ZL; Qiu B; Xu YF; Pan C; Zhang ZL
J Cancer; 2020; 11(6):1412-1423. PubMed ID: 32047548
[No Abstract] [Full Text] [Related]
13. Ecotropic virus integration-1 and calreticulin as novel prognostic markers in triple-negative breast cancer: A retrospective cohort study.
He D; Wu L; Li X; Liu X; Ma P; Juang Y
Oncol Lett; 2019 Aug; 18(2):1847-1855. PubMed ID: 31423253
[TBL] [Abstract][Full Text] [Related]
14. PBK, targeted by EVI1, promotes metastasis and confers cisplatin resistance through inducing autophagy in high-grade serous ovarian carcinoma.
Ma H; Li Y; Wang X; Wu H; Qi G; Li R; Yang N; Gao M; Yan S; Yuan C; Kong B
Cell Death Dis; 2019 Feb; 10(3):166. PubMed ID: 30778048
[TBL] [Abstract][Full Text] [Related]
15. Direct interaction between the PRDM3 and PRDM16 tumor suppressors and the NuRD chromatin remodeling complex.
Ivanochko D; Halabelian L; Henderson E; Savitsky P; Jain H; Marcon E; Duan S; Hutchinson A; Seitova A; Barsyte-Lovejoy D; Filippakopoulos P; Greenblatt J; Lima-Fernandes E; Arrowsmith CH
Nucleic Acids Res; 2019 Feb; 47(3):1225-1238. PubMed ID: 30462309
[TBL] [Abstract][Full Text] [Related]
16. Ecotropic viral integration site 1 promotes metastasis independent of epithelial mesenchymal transition in colon cancer cells.
Nayak KB; Sajitha IS; Kumar TRS; Chakraborty S
Cell Death Dis; 2018 Jan; 9(2):18. PubMed ID: 29339729
[TBL] [Abstract][Full Text] [Related]
17. Intratumoral Heterogeneity of Frameshift Mutations in MECOM Gene is Frequent in Colorectal Cancers with High Microsatellite Instability.
Choi EJ; Kim MS; Song SY; Yoo NJ; Lee SH
Pathol Oncol Res; 2017 Jan; 23(1):145-149. PubMed ID: 27620344
[TBL] [Abstract][Full Text] [Related]
18. Ecotropic viral integration site 1, a novel oncogene in prostate cancer.
Queisser A; Hagedorn S; Wang H; Schaefer T; Konantz M; Alavi S; Deng M; Vogel W; von Mässenhausen A; Kristiansen G; Duensing S; Kirfel J; Lengerke C; Perner S
Oncogene; 2017 Mar; 36(11):1573-1584. PubMed ID: 27617580
[TBL] [Abstract][Full Text] [Related]
19. Epimutational profile of hematologic malignancies as attractive target for new epigenetic therapies.
Fratta E; Montico B; Rizzo A; Colizzi F; Sigalotti L; Dolcetti R
Oncotarget; 2016 Aug; 7(35):57327-57350. PubMed ID: 27329599
[TBL] [Abstract][Full Text] [Related]
20. Mutations in MECOM, Encoding Oncoprotein EVI1, Cause Radioulnar Synostosis with Amegakaryocytic Thrombocytopenia.
Niihori T; Ouchi-Uchiyama M; Sasahara Y; Kaneko T; Hashii Y; Irie M; Sato A; Saito-Nanjo Y; Funayama R; Nagashima T; Inoue S; Nakayama K; Ozono K; Kure S; Matsubara Y; Imaizumi M; Aoki Y
Am J Hum Genet; 2015 Dec; 97(6):848-54. PubMed ID: 26581901
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
